Deliver Your News to the World

James S. McGlone Joins ChemImage Corporation as President


Pittsburgh, PA (ChemImage Corporation) – ChemImage, a leader in Chemical Imaging technology, is pleased to announce the addition of James S. McGlone to the executive management team. James S. McGlone joined ChemImage effective June 1st, 2008.

“I am very excited about the opportunity at ChemImage.”James S. McGlone stated. “I look forward to exploiting ChemImage’s strong patent portfolio and leveraging our unique Molecular and Chemical Imaging abilities. With our unique abilities we will differentiate ourselves from other suppliers of imaging technologies.”

McGlone is the most recent addition to the ChemImage management team that has been transitioning over the last seven months. “We are extremely pleased that Mr. McGlone has joined the ChemImage family,” stated John Belechak, ChemImage Chief Operating Officer. “Jim’s an experienced business professional with firmly established leadership skills. He affords ChemImage the ability to think strategically at a higher level and provides invaluable business expertise,” Belechak added.

McGlone joins ChemImage after several years as the President of Galil Medical where he drove the expansion of Galil’s cryotherapy business. McGlone was also the President of Oncura which was a joint venture between General Electric (NYSE:GE) and Galil Medical, Ltd. Prior to joining Galil Medical, McGlone spent fourteen years in various sales and management roles with Siemens Medical Systems Inc., a subsidiary of Siemens AG (NYSE:SI).

McGlone holds an MBA from Stern Business School at New York University, a MS in Bioengineering from the Pennsylvania State University and a BA in Engineering and Applied Science from Yale University.

About ChemImage
ChemImage Corporation is a world leader in Chemical Imaging technologies; provides instrumentation, software and expert consulting to government, industrial and academic organizations. ChemImage offers these products and services for a range of applications including defense, security, pharmaceuticals, forensics and biomedical diagnostic research. Our state-of-the-art Chemical Imaging technology can help to reveal critical chemical and biological information about processes, products and services.

ChemImage’s main headquarters is located in Pittsburgh, Pennsylvania and houses research and development laboratories as well as engineering and manufacturing facilities. ChemImage may be contacted at +1 412-241-7335 or at


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.